UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
Bioanalytical Systems, Inc.
(Name of Issuer)
Common Shares
(Title or Class of Securities)
09058M 10 3
(CUSIP Number)
<PAGE>
CUSIP No. 09058M 10 3
1. NAME OF REPORTING PERSON
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (Entities only)
Peter T. Kissinger, Ph.D.
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a)
(b) [X]
3. SEC USE ONLY
4. CITIZENSHIP OR PLACE OF ORGANIZATION
U.S.A.
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
<TABLE>
<CAPTION>
<S> <C>
5. SOLE VOTING POWER. . . . 430,947
6. SHARED VOTING POWER. . . 848,220
7. SOLE DISPOSITIVE POWER . 430,947
8. SHARED DISPOSITIVE POWER 848,220
</TABLE>
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,279,167
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
28.41%
12. TYPE OF REPORTING PERSON
IN
<PAGE>
SCHEDULE 13G
Item 1.
This statement relates to the Common Shares of Bioanalytical Systems, Inc.,
an Indiana corporation ("BAS"), with principal executive offices at 2701 Kent
Avenue, West Lafayette, Indiana 47906.
Item 2.
(a) - (c) This Schedule 13G is being filed by Peter T. Kissinger, Ph.D.
The principal business office of Dr. Kissinger is located at 2701 Kent Avenue,
West Lafayette, Indiana 47906. Dr. Kissinger is a United States citizen.
(d) and (e) This statement relates to the Common Shares of BAS, and the
CUSIP number for such securities is 09058M 10 3.
Item 3.
Not Applicable.
Item 4. Ownership
(a) As of the close of business on December 31, 1998, Dr. Kissinger
beneficially owned 1,279,167 Common Shares of BAS (Includes (i) 252,310 shares
beneficially owned by Candice B. Kissinger, the wife of Dr. Kissinger; and (ii)
595,910 Common Shares owned jointly by Dr. and Mrs. Kissinger).
(b) As of the close of business on December 31, 1998, the Common Shares set
forth in Item 4(a) represent approximately 28.41% of the issued and
outstanding Common Shares of BAS.
(c) (i) Dr. Kissinger has the sole power to vote 430,947 of the Common
Shares set forth in Item 4(a).
(ii) Dr. Kissinger has the shared power to vote 848,220 of the Common
Shares set forth in Item 4(a) (Includes (i) 595,910 Common Shares owned
jointly by Dr. and Mrs. Kissinger and (ii) 252,310 Common Shares beneficially
owned by Mrs. Kissinger.)
(iii) Dr. Kissinger has the sole power to dispose of 430,947 of the
Common Shares set forth in Item 4(a).2
(iv) Dr. Kissinger has the shared power to dispose of 848,220 of the
Common Shares set forth in Item 4(a).3
Items 5. Ownership of Five Percent or Less of a Class.
Not Applicable.
Item 6. Ownership of More than Five Percent on Behalf of Another Person.
Not Applicable.
Item 7. Identification and Classification of the Subsidiary Which Acquired
the Security Being Reported on by the Parent Holding Company.
Not Applicable.
Item 8. Identification and Classification of Members of the Group.
Not Applicable.
Item 9. Notice of Dissolution of a Group.
Not Applicable.
Item 10. Certification.
Not Applicable.
<PAGE>
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
Date: February 12, 1999
\S\ Peter T. Kissinger, Ph.D.
Peter T. Kissinger, Ph.D.
